Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Approval received to commence Canadian FluINsure field trial

Oct. 21, 2003

Two novel series of S1P1/edg1 agonists reported by Merck & Co.

Oct. 9, 2003

Antiinflammatory effects described for thalidomide in sepsis

Oct. 9, 2003

VaxGen awarded anthrax vaccine development contract by NIAID

Oct. 6, 2003

Positive phase I results for Cytovaxine

Oct. 6, 2003

Roche and Protein Design Labs restructure Zenapax alliance

Oct. 3, 2003

Ariad scientists design new rapamycin-based immunosuppressants

Oct. 1, 2003

FluINsure shows positive results in influenza challenge study

Sep. 25, 2003

New IgE production inhibitors in early development at Novartis

Sep. 18, 2003

Grants support work on ricin vaccine technology

Sep. 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...